After quantitative calculation, the levels of serum CCL18 and CXCL1 antigens, and C1D, TM4SF1, FXR1, and ZNF573 IgG autoantibodies were significantly higher in patients with OC than in those with cervical cancer, liver cancer, breast cancer, gynecological benign tumor patients, and healthy women (Figure 2). This evidence concerns the gene CCL18 and liver cancer.